Raycaster is an AI-native workspace for biopharma providers that leverages AI agents to accelerate commercial wins, drive R&D breakthroughs, and support regulatory compliance across the life sciences sector. The platform is specifically designed to serve companies selling complex technical products—such as instruments, reagents, CDMOs, and central labs—by transforming scattered scientific and commercial data into actionable insights and competitive advantage.
Raycaster automates critical workflows for commercial, research, and regulatory teams, helping organizations surface hidden insights about prospects and markets. Its platform enables AI agents to process research papers, patents, protocols, and contracts in real time, allowing users to identify product-opportunity fit, auto-generate tailored outreach, and streamline the creation of RFIs/RFPs and contract language.
Key features include:
- Commercial Intelligence: Score leads, automate RFP responses, and track competitor pricing.
- Competitive Analysis: Monitor emerging technologies, analyze clinical trial data, and identify market white spaces.
- RFP Generator: Create pre-filled, partner-ready RFPs rapidly.
- Patent & IP Intelligence: Track patent landscapes, manage litigation risks, and protect innovation pipelines.
- Scientific Literature Analysis: Connect publications to market trends and discover collaboration opportunities.
Raycaster's recent launch of the 'Prior-Art Flash Search' tool demonstrates its commitment to accelerating biopharma innovation. This free tool helps teams speed up freedom-to-operate (FTO) checks, filings, and litigation searches by instantly retrieving related patents, research articles, and litigation news, all exportable for further analysis.
Who Uses Raycaster?
Raycaster is built for biopharma providers and life science companies that need to manage and analyze complex data across commercial, R&D, and regulatory functions. This includes organizations such as instrument and reagent manufacturers, contract development and manufacturing organizations (CDMOs), and central laboratories. The platform is particularly suited for teams aiming to accelerate sales cycles, stay ahead of competitors, and ensure robust compliance in a fast-moving market.
How Was Raycaster Started and Who Leads the Company?
Raycaster was founded by Levi S. Lian (CEO and Co-Founder) and Anthony Humay (Co-Founder, with prior experience at Meta, Apple, and Snap). Mala Ramakrishnan is also noted as Founder and Managing Partner at Progressive Ventures. The leadership's background in technology and venture capital underpins Raycaster's focus on leveraging AI for high-value, real-world problems in the biopharma domain.
What Sets Raycaster Apart?
Raycaster differentiates itself by enabling AI agents to process diverse scientific and business data—research papers, patents, protocols, and contracts—in real time. This capability allows users to identify market opportunities, respond to commercial requests, and protect intellectual property with greater speed and accuracy than traditional manual methods. The platform's mission-critical workflows are tailored to the specific needs of the life sciences industry, making it a specialized solution for complex technical sales, innovation, and compliance challenges.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Raycaster and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.